Asian Perspective on Lung Cancer Screening

Takahiro Mimae; Morihito Okada

doi:10.1016/j.thorsurg.2023.03.004

Asian Perspective on Lung Cancer Screening

Thorac Surg Clin. 2023 Nov;33(4):385-400. doi: 10.1016/j.thorsurg.2023.03.004. Epub 2023 May 16.

Authors

Takahiro Mimae¹, Morihito Okada²

Affiliations

¹ Department of Surgical Oncology, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
² Department of Surgical Oncology, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. Electronic address: [email protected].

PMID: 37806741
DOI: 10.1016/j.thorsurg.2023.03.004

Abstract

Lung cancer is the leading cause of cancer-related mortality in Japan and worldwide. Early detection of lung cancer is an important strategy for decreasing mortality. Advances in diagnostic imaging have made it possible to detect lung cancer at an early stage in medical practice. Conversely, screening of asymptomatic healthy populations is recommended only when the evidence shows the benefits of regular intervention. Due to a variety of evidence and racial differences, screening methods vary from country to country. This article focused on the perspective of lung cancer screening in Japan.

Keywords: Chest radiography; Low-dose computed tomography; Segmentectomy; Sputum cytology; Wedge resection.

Publication types

Review

MeSH terms

Early Detection of Cancer
Humans
Lung Neoplasms* / diagnosis
Mass Screening / methods
Radiography, Thoracic
Sputum
Tomography, X-Ray Computed / methods